The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors

Head Neck. 2021 Oct;43(10):3062-3075. doi: 10.1002/hed.26801. Epub 2021 Jul 8.

Abstract

Background: Little is documented regarding objective financial metrics and their impact on subjective financial toxicity in head and neck cancer (HNC) survivors.

Methods: In a cross-sectional analysis, 71 survivors with available claims data for HNC-specific out-of-pocket expenses (OOPE) completed a survey including patient-reported, subjective financial toxicity outcome tools: the Comprehensive Score for financial Toxicity (COST) and the Financial Distress Questionnaire (FDQ).

Results: Worse COST scores were significantly associated with lower earnings at survey administration (coefficient = 3.79; 95% CI 2.63-4.95; p < 0.001); loss of earnings after diagnosis (coefficient = 6.03; 95% CI 0.53-11.52; p = 0.032); and greater annual OOPE as a proportion of earnings [log10(Annual OOPE:Earnings at survey): coefficient = -5.66; 95% CI -10.28 to -1.04; p = 0.017]. Similar results were found with FDQ.

Conclusion: Financial toxicity is associated with particular socioeconomic characteristics which, if understood, would assist the development of pre-treatment screening tools to detect at-risk individuals and intervene early in the HNC cancer survivorship trajectory.

Keywords: financial toxicity; head and neck cancer; health expenditures; health services; multidisciplinary research; out-of-pocket expenses; patient-reported outcomes; survivorship; treatment costs.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cost of Illness*
  • Cross-Sectional Studies
  • Head and Neck Neoplasms* / therapy
  • Health Expenditures
  • Humans
  • Survivors